RIGImmune is a biopharmaceutical company that is developing a new class of immune-modulating therapies for RNA virus diseases and antitumor immune response induction.

Biotechnology

Pharmaceutical

RIGImmune

Susan Sobolov

Tom Smart

Daniel Wagner

Monica Zhou

Nilesh Wadhwa

Jag Shur

Garth Rapeport

Radhakrishnan Iyer

The Leadership Team at RIGImmune, comprising the President, Chief Development Officer, and Chief Technical Officer, is responsible for setting the strategic direction, overseeing development initiatives, and guiding technical innovation to advance the company's immune-modulating therapies for RNA virus diseases and antitumor responses.

Leadership Team

Scientific and Technical Advisory

Leadership Team

About

Team members

Other teams at RIGImmune

Scientific and Technical Advisory